Metis Global Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.89M | Sell |
5,497
-810
| -13% | -$425K | 0.07% | 231 |
|
|
2025
Q1 | $4M | Buy |
6,307
+794
| +14% | +$504K | 0.11% | 159 |
|
|
2024
Q4 | $3.93M | Buy |
5,513
+169
| +3% | +$120K | 0.12% | 143 |
|
|
2024
Q3 | $5.62M | Buy |
5,344
+90
| +2% | +$94.6K | 0.18% | 96 |
|
|
2024
Q2 | $5.52M | Buy |
5,254
+21
| +0.4% | +$22.1K | 0.19% | 86 |
|
|
2024
Q1 | $5.04M | Buy |
5,233
+7
| +0.1% | +$6.74K | 0.18% | 96 |
|
|
2023
Q4 | $4.59M | Sell |
5,226
-244
| -4% | -$214K | 0.18% | 101 |
|
|
2023
Q3 | $4.5M | Buy |
5,470
+694
| +15% | +$571K | 0.22% | 93 |
|
|
2023
Q2 | $3.43M | Buy |
4,776
+83
| +2% | +$59.6K | 0.18% | 109 |
|
|
2023
Q1 | $3.86M | Buy |
4,693
+600
| +15% | +$493K | 0.25% | 83 |
|
|
2022
Q4 | $2.95M | Buy |
4,093
+1,139
| +39% | +$822K | 0.26% | 87 |
|
|
2022
Q3 | $2.03M | Buy |
2,954
+98
| +3% | +$67.5K | 0.33% | 61 |
|
|
2022
Q2 | $1.69M | Buy |
2,856
+788
| +38% | +$466K | 0.27% | 83 |
|
|
2022
Q1 | $1.44M | Buy |
2,068
+765
| +59% | +$534K | 0.17% | 112 |
|
|
2021
Q4 | $822K | Buy |
+1,303
| New | +$822K | 0.23% | 99 |
|